TW221429B - - Google Patents

Info

Publication number
TW221429B
TW221429B TW081108253A TW81108253A TW221429B TW 221429 B TW221429 B TW 221429B TW 081108253 A TW081108253 A TW 081108253A TW 81108253 A TW81108253 A TW 81108253A TW 221429 B TW221429 B TW 221429B
Authority
TW
Taiwan
Prior art keywords
optionally substituted
hydrogen
cycloalkyl
alkyl
compound
Prior art date
Application number
TW081108253A
Other languages
English (en)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of TW221429B publication Critical patent/TW221429B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW081108253A 1991-10-21 1992-10-16 TW221429B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30234891 1991-10-21

Publications (1)

Publication Number Publication Date
TW221429B true TW221429B (zh) 1994-03-01

Family

ID=17907840

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081108253A TW221429B (zh) 1991-10-21 1992-10-16

Country Status (12)

Country Link
US (2) US5378698A (zh)
EP (2) EP0615971B1 (zh)
JP (1) JP2818082B2 (zh)
KR (1) KR100214902B1 (zh)
CN (1) CN1034075C (zh)
AT (2) ATE116974T1 (zh)
CA (1) CA2080671A1 (zh)
DE (2) DE69201184T2 (zh)
DK (2) DK0541263T3 (zh)
ES (2) ES2069967T3 (zh)
GR (1) GR3024453T3 (zh)
TW (1) TW221429B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2197816A1 (en) * 1996-02-23 1997-08-24 Tanabe Seiyaku Co., Ltd. Process for preparing 1,5-benzothiazepine derivative
IL123352A0 (en) 1997-02-27 1998-09-24 Tanabe Seiyaku Co Process for preparing an optically active trans-3-substituted glycidic acid ester
UA67760C2 (uk) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6897305B2 (en) * 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
US7101909B2 (en) * 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
CN1872846B (zh) * 1999-07-09 2010-06-16 宇部兴产株式会社 二苯并硫氮*衍生物的制备方法
EP2090663A3 (en) * 2000-06-28 2009-11-11 Takeda Pharmaceutical Company Limited Method of preparing heart muscle cells and method of searching for remedy for heart diseases
MXPA04006281A (es) 2001-12-28 2004-09-27 Acadia Pharm Inc Analogos de tetrahidroquinolina como agonistas muscarinicos.
US7550459B2 (en) 2001-12-28 2009-06-23 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075967A (en) * 1961-06-12 1963-01-29 Olin Mathieson Benzothiazines
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US5028610A (en) * 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures
US4963545A (en) * 1988-05-24 1990-10-16 Marion Laboratories, Inc. Benzothiazepine anti-seizure method
FR2645744B1 (fr) * 1989-04-13 1994-01-21 Roussel Uclaf Derives de la benzothiazepine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
CA2030159A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Anti-cancer drug potentiators
US5001236A (en) * 1989-11-22 1991-03-19 Marion Laboratories, Inc. Benzothiazepines

Also Published As

Publication number Publication date
DE69201184D1 (de) 1995-02-23
EP0541263A1 (en) 1993-05-12
CN1073168A (zh) 1993-06-16
JP2818082B2 (ja) 1998-10-30
CN1034075C (zh) 1997-02-19
JPH05201865A (ja) 1993-08-10
DK0615971T3 (da) 1997-10-06
EP0615971A1 (en) 1994-09-21
DE69221634T2 (de) 1998-01-15
US5462936A (en) 1995-10-31
ATE156821T1 (de) 1997-08-15
ES2106439T3 (es) 1997-11-01
DE69201184T2 (de) 1995-06-08
DE69221634D1 (de) 1997-09-18
EP0615971B1 (en) 1997-08-13
GR3024453T3 (en) 1997-11-28
ES2069967T3 (es) 1995-05-16
DK0541263T3 (da) 1995-04-18
US5378698A (en) 1995-01-03
KR100214902B1 (ko) 1999-08-02
ATE116974T1 (de) 1995-01-15
CA2080671A1 (en) 1993-04-22
KR930007943A (ko) 1993-05-20
EP0541263B1 (en) 1995-01-11

Similar Documents

Publication Publication Date Title
AU1539088A (en) Heterocyclic ketones
EP0976748A4 (en) PYRROLIDINE DERIVATIVES HAVING PHOSPHOLIPASE A2 INHIBITING ACTIVITY
AU8405891A (en) Indole derivative and medicine
TW221429B (zh)
EP0299493A3 (en) N-û(2-oxopyrrolidin-1-yl)-acetyl¨piperazine derivatives and drug for senile dementia
PH24309A (en) Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof
IL85768A (en) Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
GR3001955T3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
NZ227682A (en) Thioformamide derivatives, preparation thereof and pharmaceutical compositions
EP0555479A4 (zh)
DE3674546D1 (de) Amidderivate.
GB8515212D0 (en) Thiazolidine derivatives
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative